Search

Oluwatosin A. Ogunbiyi

Examiner (ID: 17664, Phone: (571)272-9939 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645
Total Applications
1148
Issued Applications
603
Pending Applications
160
Abandoned Applications
405

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17759995 [patent_doc_number] => 20220233607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => TOXOPLASMA PLATFORM FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/614771 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27482 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614771 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/614771
TOXOPLASMA PLATFORM FOR TREATING CANCER May 28, 2020 Abandoned
Array ( [id] => 16451025 [patent_doc_number] => 20200360451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => FERMENTED MILK FOR IMPROVING AUTONOMIC FUNCTION [patent_app_type] => utility [patent_app_number] => 16/864486 [patent_app_country] => US [patent_app_date] => 2020-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4739 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864486 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/864486
FERMENTED MILK FOR IMPROVING AUTONOMIC FUNCTION Apr 30, 2020 Abandoned
Array ( [id] => 17089990 [patent_doc_number] => 11118170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-14 [patent_title] => Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells [patent_app_type] => utility [patent_app_number] => 16/854551 [patent_app_country] => US [patent_app_date] => 2020-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7977 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854551 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/854551
Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells Apr 20, 2020 Issued
Array ( [id] => 17930161 [patent_doc_number] => 20220325286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => POLYPEPTIDE COMBINATION USED FOR TUMOUR IMMUNOTHERAPY, AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/605472 [patent_app_country] => US [patent_app_date] => 2020-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12618 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605472 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/605472
Polypeptide combination used for tumour immunotherapy, and preparation method therefor Apr 19, 2020 Issued
Array ( [id] => 17735996 [patent_doc_number] => 20220221455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => ANTIGEN BINDING PROTEINS AND ASSAYS [patent_app_type] => utility [patent_app_number] => 17/604008 [patent_app_country] => US [patent_app_date] => 2020-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30456 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604008 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/604008
ANTIGEN BINDING PROTEINS AND ASSAYS Apr 15, 2020 Abandoned
Array ( [id] => 18186310 [patent_doc_number] => 11576868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Method for reducing zoonotic infectious diseases [patent_app_type] => utility [patent_app_number] => 16/848841 [patent_app_country] => US [patent_app_date] => 2020-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15058 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848841 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/848841
Method for reducing zoonotic infectious diseases Apr 14, 2020 Issued
Array ( [id] => 17671032 [patent_doc_number] => 20220184199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/601949 [patent_app_country] => US [patent_app_date] => 2020-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 128838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601949 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/601949
IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF Apr 5, 2020 Abandoned
Array ( [id] => 19013206 [patent_doc_number] => 11920124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Method of producing lactic acid bacteria dual-coated with protein and polysaccharide by using protein hydrolysate [patent_app_type] => utility [patent_app_number] => 16/839289 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7889 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 314 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839289 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/839289
Method of producing lactic acid bacteria dual-coated with protein and polysaccharide by using protein hydrolysate Apr 2, 2020 Issued
Array ( [id] => 16359435 [patent_doc_number] => 20200316186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => MULTI-SUBUNIT VACCINES TO ELICIT BOTH MHC- AND CD1-RESTRICTED T CELL RESPONSES [patent_app_type] => utility [patent_app_number] => 16/839861 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26467 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839861 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/839861
Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses Apr 2, 2020 Issued
Array ( [id] => 17073782 [patent_doc_number] => 11110161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-07 [patent_title] => Vaccine for prophylaxis or treatment of an allergen-driven airway pathology [patent_app_type] => utility [patent_app_number] => 16/840276 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4815 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840276 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/840276
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology Apr 2, 2020 Issued
Array ( [id] => 16539426 [patent_doc_number] => 20200405839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => VACCINE FORMULATION TO PROTECT AGAINST PERTUSSIS [patent_app_type] => utility [patent_app_number] => 16/832490 [patent_app_country] => US [patent_app_date] => 2020-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10279 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832490 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/832490
Vaccine formulation to protect against pertussis Mar 26, 2020 Issued
Array ( [id] => 16204898 [patent_doc_number] => 20200237888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => COMPOSITIONS COMPRISING RECOMBINANT PROBIOTIC BACTERIA AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/813131 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813131 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/813131
COMPOSITIONS COMPRISING RECOMBINANT PROBIOTIC BACTERIA AND METHODS OF USE THEREOF Mar 8, 2020 Abandoned
Array ( [id] => 17905535 [patent_doc_number] => 11459379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Immunoreactive protein orthologs of [patent_app_type] => utility [patent_app_number] => 16/809105 [patent_app_country] => US [patent_app_date] => 2020-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 38400 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809105 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/809105
Immunoreactive protein orthologs of Mar 3, 2020 Issued
Array ( [id] => 16282646 [patent_doc_number] => 20200276248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING COCAINE ADDICTION [patent_app_type] => utility [patent_app_number] => 16/804815 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12913 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804815 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/804815
Compositions and methods for treating or ameliorating cocaine addiction Feb 27, 2020 Issued
Array ( [id] => 17561757 [patent_doc_number] => 20220125906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM [patent_app_type] => utility [patent_app_number] => 17/434349 [patent_app_country] => US [patent_app_date] => 2020-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434349 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/434349
TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM Feb 26, 2020 Pending
Array ( [id] => 16359393 [patent_doc_number] => 20200316144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/798831 [patent_app_country] => US [patent_app_date] => 2020-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13576 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798831 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/798831
BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS Feb 23, 2020 Abandoned
Array ( [id] => 18544211 [patent_doc_number] => 11717542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-08 [patent_title] => Using tumor-navigating [patent_app_type] => utility [patent_app_number] => 17/433225 [patent_app_country] => US [patent_app_date] => 2020-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9915 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433225 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/433225
Using tumor-navigating Feb 19, 2020 Issued
Array ( [id] => 17967051 [patent_doc_number] => 11484556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Nutrient rich germinant composition and spore incubation method [patent_app_type] => utility [patent_app_number] => 16/785138 [patent_app_country] => US [patent_app_date] => 2020-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5006 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785138 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/785138
Nutrient rich germinant composition and spore incubation method Feb 6, 2020 Issued
Array ( [id] => 17967077 [patent_doc_number] => 11484582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Methods and compositions for immune protection against extra-intestinal pathogenic [patent_app_type] => utility [patent_app_number] => 16/781526 [patent_app_country] => US [patent_app_date] => 2020-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 21439 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16781526 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/781526
Methods and compositions for immune protection against extra-intestinal pathogenic Feb 3, 2020 Issued
Array ( [id] => 17666400 [patent_doc_number] => 11360085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Bacterial endotoxin test for the determination of endotoxins [patent_app_type] => utility [patent_app_number] => 16/774461 [patent_app_country] => US [patent_app_date] => 2020-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 27683 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774461 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/774461
Bacterial endotoxin test for the determination of endotoxins Jan 27, 2020 Issued
Menu